Viewing nowCombinationTelmitwin Tablet 80/5 mg
Telmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Hanpung Pharmaceutical Co., Ltd.

MFDS item code 201905316 · Approved 2019.07.26 · Insurance code 658106750
Treatment of essential hypertension not controlled with monotherapy
This medication is used as an adjunct treatment for patients with essential hypertension whose blood pressure is not adequately controlled with amlodipine or telmisartan monotherapy. It helps to effectively lower and control blood pressure, reducing the risk of cardiovascular complications. It is designed to enable appropriate blood pressure management tailored to the patient's condition.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose of each individual component (amlodipine or telmisartan) be adjusted before starting this medicine. However, a direct switch to this medicine may be considered if blood pressure is not controlled with the individual components, as follows: - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients who should be treated with caution’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients aged 18 years and younger; therefore, its use is not recommended.
This drug may pose serious risks to the fetus, especially during the second and third trimesters of pregnancy, so women who are pregnant or may become pregnant should not use it. This drug is contraindicated in patients with certain diseases. For example, patients with cholestatic diseases, severe liver impairment, severe hypotension, cardiogenic shock, or unstable blood flow after acute myocardial infarction should not take this medication. Additionally, individuals allergic to the main ingredient or similar medications, and nursing mothers should also avoid using this drug. Patients with primary aldosteronism, aortic or mitral stenosis, liver impairment, gastrointestinal diseases, renal artery hypertension, dialysis patients, elderly patients, etc., require special caution when using this drug. Common side effects such as dizziness or peripheral edema may occur while using this medication, and rarely, fainting or heart-related adverse reactions may also occur. This drug can interact with other medications, so if you are taking other drugs, be sure to consult a doctor or pharmacist. Pregnant women should not use this drug, and if pregnancy is confirmed, immediate discontinuation and seeking alternative treatment is necessary. Symptoms of low blood pressure may occur, so patients, especially those with fluids or salt deficiency, should be cautious. Due to the risk of hyperkalemia, it is important to regularly check potassium levels in the blood. Patients with decreased renal function should also periodically monitor renal function while using this drug. This drug may cause drowsiness or dizziness while driving or operating machinery, so caution is required. In case of overdose, symptoms such as blood pressure drops and heart function abnormalities may appear, necessitating immediate treatment. Finally, keep this product out of the reach of children, and it is recommended to unwrap the package just before use.
Not everyone experiences these, and they can vary from person to person.
This drug is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it is important to maintain the storage temperature between 1 degree Celsius and 30 degrees Celsius to preserve the effectiveness of the medication over time.
This is a white and light gray, biconvex, oval-shaped double-layer tablet.
30 tablets/PTP [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Hanpung Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.